Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0002871 (anemia)
 52,094 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

This article reviews the pathophysiologic concept that superoxide and hydrogen peroxide, generated by activated leukocytes, together with low-molecular-weight chelate iron derived from fecal sources and from denatured hemoglobin, amplify the inflammatory response and subsequent mucosal damage in patients with active episodes of ulcerative colitis. The putative pathogenic mechanisms reviewed are as follows: (1) Dietary iron is concentrated in fecal material owing to normally limited iron absorption. (2) Mucosal bleeding, characteristic of ulcerative colitis, as well as supplemental oral iron therapy for chronic anemia, further conspire to maintain or elevate mucosal iron concentration in colitis. (3) Fenton chemistry, driven especially by leukocyte-generated superoxide and hydrogen peroxide, leads to formation of hydroxyl radicals. (4) The resultant oxidative stress leads to the extension and propagation of crypt abscesses, either through direct membrane disruption by lipid peroxidation or through generation of secondary toxic oxidants such as chloramines. (5) Chemotactic products of lipid peroxidation, including 4-hydroxynonenal, provide positive feedback to accelerate this inflammatory/oxidative process, leading to acute exacerbations of the disease. (6) Other oxidized products, such as oxidized tryptophan metabolites, created by free radical mechanisms in or near the mucosa, may act as carcinogens or tumor promotors that contribute to the exceedingly high incidence of colon carcinoma in patients suffering from chronic ulcerative colitis. In this way, self-sustaining cycles of oxidant formation may amplify flare-ups of inflammation and mucosal injury in ulcerative colitis. This concept, if proved correct by subsequent research, would provide a rationale for several novel clinical approaches to the management of ulcerative colitis, including use of SOD mimetics, iron chelators, and chain-breaking antioxidants.
 ...
PMID:Oxygen radicals in ulcerative colitis. 135 59

A case of adenocarcinoma of the sigmoid colon during pregnancy is reported. The patient presented with anemia and a painless mass over the left abdomen without gastrointestinal discomfort, making this case different from 25 previously reported cases of colon carcinoma above the peritoneal reflection associated with pregnancy.
 ...
PMID:Cancer of the colon during pregnancy: report of a case and review of the literature. 136 70

In vitro results have clearly demonstrated that leucovorin (LV) can enhance the growth inhibitory effects of 5-fluorouracil (5FU) but in vivo potentiation of the antitumor effect of 5FU by LV has not yet been defined in animal models. The antitumor effect and the toxicity of the LV-5FU combination was studied in mice bearing the colon carcinomas, Colon 26 and Colon 38. Mice were treated weekly with 5FU at the maximum tolerated dose (100 mg/kg) alone or with LV at different doses and schedules. Pretreatment with LV followed 1 hr later by a second LV injection together with 5FU clearly potentiated the antitumor effect of 5FU in both murine tumor lines. Comparable results were obtained with total LV doses of 100 and 200 mg/kg. The effect of 5FU pretreatment was studied by randomization of 5FU pretreated Colon 38-bearing mice in 2 groups, one treated with 5FU and the other with LV-LV + 5FU. Again, LV potentiated the effect of 5FU. Also in a Colon 38 tumor which had developed resistance against 5FU and which was reimplanted, LV potentiated the antitumor activity of 5FU. Weight loss of the combination was slightly higher than for 5FU alone. A moderate leukopenia (nadir 40%) and mild anemia were observed, which were less than for 5FU alone. The combination did not cause thrombocytopenia. In conclusion, LV can potentiate the therapeutic efficacy of 5FU in murine colon carcinoma.
 ...
PMID:In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma. 306 23

A patient had an ascending colon carcinoma in a right inguinal hernia sac, the first such instance to be reported. A second patient had a left colon carcinoma in a left inguinal hernia sac. Both patients had gastrointestinal symptoms and anemia which warranted a barium enema.
 ...
PMID:Colon carcinoma in a right inguinal hernia. 738 Aug 77

To determine the clinical significance of finding occult blood in a stool sample obtained during digital rectal examination of patients with no gastrointestinal complaints, we reviewed the records of patients who had colonoscopy for this indication. Of the 185 patients (average age, 59.4 years) who met study criteria, 48 were inpatients when the Hemoccult-positive rectal examination was recorded. Neoplastic lesions were found in 28% of the patients (51/185). Thirteen of the lesions were adenocarcinomas and 38 were adenomatous polyps. Seventy-five patients (41%) had normal findings on colonoscopy. Nonneoplastic lesions were found in the remaining 32%. Comparison of patients with neoplastic lesions and patients with nonneoplastic lesions showed no significant difference with respect to the presence of anemia (43% vs 48%), inpatient status at the time of positive rectal examination (23% vs 29%), or sex. Although the mean age was similar in patients with and without neoplastic lesions (60.5 and 56.8 years, respectively), no neoplastic lesions were found in patients less than 45 years old. We conclude that testing stool obtained during rectal examination for occult blood does not increase the rate of false-positive results, and positive test should prompt a structural evaluation of the colon to detect neoplasia in patients with an age-related risk for colon carcinoma.
 ...
PMID:Is a Hemoccult-positive rectal examination clinically significant? 850 76

A 86-year-old woman hospitalized for analysis of persistent abdominal discomfort died, apparently of myocardial infarction, shortly after admission. Autopsy revealed extensive myocarditis caused by infection with Clostridium septicum. As a portal of entry a carcinoma of the colon was found. The association of colon carcinoma and bacteraemia with C. septicum is well established while colon carcinoma can lead to cardiac hypoxia through blood loss and anaemia. However, myocarditis caused by this organism is extremely rare.
 ...
PMID:[Gas gangrene of ischemic myocardial tissue caused by Clostridium septicum]. 905 45

Epidemiological studies indicate that nonsteroidal anti-inflammatory agents may reduce colorectal cancer incidence and mortality. Moreover, sulindac has been shown to attenuate the growth and progression of colonic neoplasms in an experimental model of colon carcinoma and in patients with familial adenomatous polyposis. To determine whether sulindac (300 mg/day) would increase toxicity associated with 5-fluorouracil (5-FU) and levamisole, 15 patients with advanced colorectal cancer were treated. Median treatment duration was 3 (range, 0.6-6.0) months, and median age was 56 years (33% >/= 60 years). All patients had failed prior 5-FU-based therapy, had measurable disease, and were evaluable for toxicity. Grade III/IV granulocytopenia occurred in four patients; three patients had received prior pelvic irradiation resulting in a predisposition to myelosuppression. Two patients developed grade III anemia, and occult gastrointestinal bleeding was suspected in one. No other grade II or greater gastrointestinal or other nonhematological toxicity occurred. One patient had a partial response, 3 patients had disease stabilization, and 10 patients progressed on study. Our results indicate that sulindac does not significantly increase short-term toxicity associated with 5-FU and levamisole. To determine whether sulindac increases the efficacy of adjuvant chemotherapy, we propose a phase III randomized trial in patients with lymph node-positive colon cancer.
 ...
PMID:Phase I trial of sulindac plus 5-fluorouracil and levamisole: potential adjuvant therapy for colon carcinoma. 981 87

A 74-year-old Japanese man was admitted to our hospital with anemia, 4 years after a thymectomy for thymoma associated with myasthenia gravis. A diagnosis of sigmoid colon carcinoma was confirmed, followed by surgical resection. This case is presented to reinforce that physicians should bear in mind the possibility of extrathymic malignancies in patients with thymoma.
 ...
PMID:Colon carcinoma after thymectomy for myasthenia gravis: report of a case. 1237 88

Although it generally does not improve performance, iron is often used by elite athletes. The physiologic changes induced by exercise can mimic iron deficiency and decrease hemoglobin and ferritin concentrations. Determination of serum transferrin receptor concentrations may identify true iron deficiency, which occurs particularly in young athletes. In contrast, increased iron stores in the body are a frequent finding in elite athletes who have used long-term iron supplementation. Elite runners have increased intestinal blood loss, but this usually can be compensated by enhanced absorption of dietary iron. The combination of exercise-induced hemolysis with enhanced intestinal blood loss in various endurance sports leads to severe abnormalities of routine tests, and extreme physical activity may be responsible for positive fecal occult blood determinations. Indiscriminate iron supplementation carries the risk of inducing hemochromatosis in individuals homozygous for the widespread C282Y allele of the HFE gene. This polymorphism is common and can be found in about 1% of individuals of Northern European descent; moreover, iron supplementation can modify the presentation of important underlying diseases such as celiac disease or colon carcinoma. In conclusion, iron supplements should be prescribed for athletes with iron-deficiency anemia and carefully monitored if given for prophylaxis; unless a therapeutic response occurs, investigations to establish the cause of iron deficiency should be initiated.
 ...
PMID:Iron supplementation in athletes--first do no harm. 1521 43

Malignant duodenocolic fistulas are the most rare and evolutive complication of colonic cancer due to their rapid nutritional disturbances and difficult surgical management. This case report details a 23-year-old female who presented with diarrhea, anorexia, weight loss, anemia and abdominal pain. A series of examinations showed a transverse colon carcinoma with a malignant duodenocolic fistula and direct infiltration of the right lobe of the liver. The patient underwent extended right hemicolectomy with wide local excision of the duodenum and segmental hepatic resection. Postoperative recovery was uneventful. The analysis of other similar cases from the literature treated with this procedure or less frequently, with right hemicolectomy and pancreaticoduodenectomy, allows us to discuss the indications and results of radical surgery. Whenever feasible, resection offers the best treatment as lesser techniques such as bypass and exclusion result only in minimal palliation. The benefit of exploration should almost always be offered, even in such secondary fistulas, as a better quality of life and long term survival are realistic goals and prognostically justifiable.
 ...
PMID:Malignant duodenocolic fistula. Various therapeutic surgical modalities. 1532 10


1 2 3 Next >>